New Publication - European Radiology Experimental

Heimer at al. show that a novel intravenous Tantalum oxide nanoparticle contrast agent provides contrast advantages compared to opamidol for improved visualization of thoracic arteries and veins in a multiphase CT protocol.

Link zur Publikation